| Year |
Citation |
Score |
| 2020 |
McAndrew NP, Dickson MA, Clark AS, Troxel AB, O'Hara MH, Colameco C, Gallager M, Gramlich K, Zafman K, Vaughn D, Schwartz GK, O'Dwyer PJ, DeMichele A. Early treatment-related neutropenia predicts response to palbociclib. British Journal of Cancer. PMID 32641862 DOI: 10.1038/S41416-020-0967-7 |
0.311 |
|
| 2019 |
Schmitz KH, Troxel AB, Dean LT, DeMichele A, Brown JC, Sturgeon K, Zhang Z, Evangelisti M, Spinelli B, Kallan MJ, Denlinger C, Cheville A, Winkels RM, Chodosh L, Sarwer DB. Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial. Jama Oncology. PMID 31415063 DOI: 10.1001/Jamaoncol.2019.2109 |
0.325 |
|
| 2019 |
Darvishian F, Ozerdem U, Adams S, Chun J, Pirraglia E, Kaplowitz E, Guth A, Axelrod D, Shapiro R, Price A, Troxel A, Schnabel F, Roses D. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS). Annals of Surgical Oncology. PMID 31240590 DOI: 10.1245/S10434-019-07562-X |
0.312 |
|
| 2019 |
Liu T, Volpp KG, Asch DA, Zhu J, Wang W, Wu R, Troxel AB, Finnerty DD, Hoffer K, Shea JA. The association of financial incentives for low density lipoprotein cholesterol reduction with patient activation and motivation. Preventive Medicine Reports. 14: 100841. PMID 30911461 DOI: 10.1016/J.Pmedr.2019.100841 |
0.329 |
|
| 2019 |
Clark AS, McAndrew NP, Troxel A, Feldman M, Lal P, Rosen M, Burrell J, Redlinger C, Gallgher M, Bradbury AR, Domchek SM, Fox KR, O'Dwyer PJ, DeMichele AM. Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30635336 DOI: 10.1158/1078-0432.Ccr-18-0790 |
0.328 |
|
| 2019 |
Kwa MJ, Tray N, Esteva FJ, Novik Y, Speyer JL, Oratz R, Meyers MI, Muggia F, Ty V, Troxel A, Schneider R, Adams S. Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer. Journal of Clinical Oncology. 37: TPS604-TPS604. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps604 |
0.354 |
|
| 2018 |
Tray N, Taff J, Singh B, Suh J, Ngo N, Kwa M, Troxel AB, Chae YK, Kurzrock R, Patel SP, Sharon E, Denkert C, Ross JS, Adams S. Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes. Breast (Edinburgh, Scotland). 44: 29-32. PMID 30609392 DOI: 10.1016/J.Breast.2018.12.010 |
0.311 |
|
| 2018 |
Brown JC, Rhim AD, Manning SL, Brennan L, Mansour AI, Rustgi AK, Damjanov N, Troxel AB, Rickels MR, Ky B, Zemel BS, Courneya KS, Schmitz KH. Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer. Plos One. 13: e0204875. PMID 30332430 DOI: 10.1371/Journal.Pone.0204875 |
0.317 |
|
| 2018 |
Spinelli B, Kallan MJ, Zhang X, Cheville A, Troxel A, Cohn J, Dean L, Sturgeon K, Evangelista M, Zhang Z, Ebaugh D, Schmitz KH. Intra- and Interrater Reliability and Concurrent Validity of a New Tool for Assessment of Breast Cancer related Lymphedema of the Upper Extremity (CLUE). Archives of Physical Medicine and Rehabilitation. PMID 30291828 DOI: 10.1016/J.Apmr.2018.08.185 |
0.325 |
|
| 2018 |
McAndrew NP, Dickson MA, Clark AS, Troxel A, Colameco C, Gallagher M, Gramlich K, Zafman K, Vaughn DJ, Schwartz GK, O'Dwyer PJ, DeMichele A. Neutropenia and response to single agent palbociclib. Journal of Clinical Oncology. 36: 1043-1043. DOI: 10.1200/Jco.2018.36.15_Suppl.1043 |
0.355 |
|
| 2018 |
Taff J, Suh J, Singh B, Denkert C, Troxel A, Ross J, Adams S. Abstract P3-05-03: Metaplastic breast cancers: Genomic profile, mutational burden and TILs Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-05-03 |
0.311 |
|
| 2017 |
Rosenthal MB, Troxel AB, Volpp KG, Stewart WF, Sequist TD, Jones JB, Hirsch AG, Hoffer K, Zhu J, Wang W, Hodlofski A, Finnerty D, Huang JJ, Asch DA. Moderating Effects of Patient Characteristics on the Impact of Financial Incentives. Medical Care Research and Review : McRr. 1077558717707313. PMID 29148344 DOI: 10.1177/1077558717707313 |
0.32 |
|
| 2017 |
Brown JC, Zemel BS, Troxel AB, Rickels MR, Damjanov N, Ky B, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH. Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial. British Journal of Cancer. PMID 28934762 DOI: 10.1038/Bjc.2017.339 |
0.317 |
|
| 2017 |
Sturgeon KM, Hackley R, Fornash A, Dean LT, Laudermilk M, Brown JC, Sarwer DB, DeMichele AM, Troxel AB, Schmitz KH. Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema. Cancer. PMID 28881471 DOI: 10.1002/Cncr.30935 |
0.331 |
|
| 2017 |
Winkels RM, Sturgeon KM, Kallan MJ, Dean LT, Zhang Z, Evangelisti M, Brown JC, Sarwer DB, Troxel AB, Denlinger C, Laudermilk M, Fornash A, DeMichele A, Chodosh LA, Schmitz KH. The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema. Contemporary Clinical Trials. PMID 28739540 DOI: 10.1016/J.Cct.2017.07.017 |
0.338 |
|
| 2017 |
Brown JC, Troxel AB, Ky B, Damjanov N, Zemel BS, Rickels MR, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH. Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II Trial. Clinical Colorectal Cancer. PMID 28669606 DOI: 10.1016/J.Clcc.2017.06.001 |
0.316 |
|
| 2017 |
Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, et al. Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Research and Treatment. PMID 28653249 DOI: 10.1007/S10549-017-4339-9 |
0.312 |
|
| 2017 |
O'Hara MH, Karasic TB, Vasilevskaya I, Redlinger M, Loaiza-Bonilla A, Teitelbaum UR, Giantonio BJ, Damjanov N, Reiss KA, Rosen MA, Heitjan DF, Troxel AB, Amaravadi RK, O'Dwyer PJ. Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 35: 3545-3545. DOI: 10.1200/Jco.2017.35.15_Suppl.3545 |
0.351 |
|
| 2017 |
Lin RJ, Ma H, Guo R, Grossbard ML, Troxel AB, Magid Diefenbach CS. Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities. Journal of Clinical Oncology. 35: 10039-10039. DOI: 10.1200/Jco.2017.35.15_Suppl.10039 |
0.314 |
|
| 2017 |
Clark A, Wang X, Troxel A, Burrell J, Feldman M, Lal P, Zhang P, Rosen M, Gallagher M, Ndicu J, Nivar I, Matro J, Domchek S, Fox K, O'Dwyer P, et al. Abstract P4-22-14: Single agent palbociclib with or without trastuzumab for the treatment of Rb+ advanced breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P4-22-14 |
0.319 |
|
| 2016 |
Bauml JM, Troxel A, Epperson CN, Cohen RB, Schmitz K, Stricker C, Shulman LN, Bradbury A, Mao JJ, Langer CJ. Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung Cancer (Amsterdam, Netherlands). 100: 110-3. PMID 27597289 DOI: 10.1016/J.Lungcan.2016.08.002 |
0.317 |
|
| 2016 |
Dean LT, Kumar A, Kim T, Herling M, Brown JC, Zhang Z, Evangelisti M, Hackley R, Kim J, Cheville A, Troxel AB, Schwartz JS, Schmitz KH. Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema. Journal of Obesity. 2016: 8241710. PMID 27433356 DOI: 10.1155/2016/8241710 |
0.329 |
|
| 2016 |
Courtright KR, Madden V, Gabler NB, Cooney E, Small DS, Troxel A, Casarett D, Ersek M, Cassel JB, Nicholas LH, Escobar G, Hill SH, O'Brien D, Vogel M, Halpern SD. Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial. Annals of the American Thoracic Society. PMID 27348271 DOI: 10.1513/Annalsats.201604-308Ot |
0.303 |
|
| 2016 |
Brown JC, Troxel AB, Ky B, Damjanov N, Zemel BS, Rickels MR, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH. A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results. Contemporary Clinical Trials. PMID 26970181 DOI: 10.1016/J.Cct.2016.03.001 |
0.33 |
|
| 2016 |
Clark A, O'Dwyer P, Troxel A, Lal P, Feldman M, Gallagher M, Driscoll A, Colameco C, Lewis D, Rosen M, Matro J, Bradbury A, Domchek S, Fox K, DeMichele A. Abstract P6-13-08: Palbociclib and paclitaxel on an alternating schedule for advanced breast cancer: Results of a phase Ib trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-13-08 |
0.315 |
|
| 2016 |
Soucier-Ernst D, Colameco C, Troxel A, Clark C, Shih N, Maxwell K, Morrissette J, Lieberman D, Feldman M, Goodman N, Bradbury A, Clark A, Domchek S, Fox K, Glick J, et al. Abstract P6-07-05: Mutational spectrum and tumor response in metastatic breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-07-05 |
0.33 |
|
| 2015 |
Asch DA, Troxel AB, Stewart WF, Sequist TD, Jones JB, Hirsch AG, Hoffer K, Zhu J, Wang W, Hodlofski A, Frasch AB, Weiner MG, Finnerty DD, Rosenthal MB, Gangemi K, et al. Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial. Jama. 314: 1926-1935. PMID 26547464 DOI: 10.1001/Jama.2015.14850 |
0.3 |
|
| 2015 |
Ogdie A, Troxel AB, Mehta NN, Gelfand JM. Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3. The Journal of Investigative Dermatology. 135: 2148-50. PMID 26269404 DOI: 10.1038/Jid.2015.218 |
0.304 |
|
| 2015 |
Brown JC, Kumar A, Cheville AL, Tchou JC, Troxel AB, Harris SR, Schmitz KH. Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 94: 288-96. PMID 25171662 DOI: 10.1097/Phm.0000000000000178 |
0.325 |
|
| 2015 |
Miller TP, Li Y, Kavcic M, Alonzo TA, Hall M, Huang Y, Gerbing RB, Fisher B, Luger SM, Rubin D, Troxel AB, Sung L, Gamis AS, Aplenc R. Accuracy of adverse event reporting on a phase III clinical trial for pediatric acute myeloid leukemia: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 33: 10028-10028. DOI: 10.1200/Jco.2015.33.15_Suppl.10028 |
0.313 |
|
| 2015 |
DeMichele AM, Colameco CB, Kalota A, Troxel AB, Holmes R, Cimildoro R, Zafman K, Fox KR, Domchek SM, Gogineni K, Bradbury AR, Matro JM, Shih N, Feldman MD, Clark AS, et al. Abstract CT114: A phase II trial of exemestane and ruxolitinib for aI-resistant ER+ breast cancer: Interim safety, efficacy, and biomarker analysis Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct114 |
0.362 |
|
| 2015 |
Maxwell KN, Soucier-Ernst DJ, Carpenter EL, Troxel AB, Colameco C, Clark C, Feldman MD, Kakrecha B, Langer M, Lee J, Lewis DA, Lieberman D, Morrissette J, Pan T, Yee SS, et al. Abstract 618: Comparison of mutational spectra in metastatic tumors and cell-free DNA in breast cancer patients Cancer Research. 75: 618-618. DOI: 10.1158/1538-7445.Am2015-618 |
0.319 |
|
| 2014 |
Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel AB, Tan KS, Heitjan DF, DeMichele AM, Vaughn DJ, Redlinger M, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 10: 1391-402. PMID 24991838 DOI: 10.4161/Auto.29119 |
0.324 |
|
| 2014 |
Farrar JT, Troxel AB, Haynes K, Gilron I, Kerns RD, Katz NP, Rappaport BA, Rowbotham MC, Tierney AM, Turk DC, Dworkin RH. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study. Pain. 155: 1622-31. PMID 24831421 DOI: 10.1016/J.Pain.2014.05.009 |
0.309 |
|
| 2014 |
Dommasch ED, Troxel AB, Gelfand JM. Counterpoint: A tale of two meta-analyses revisited. Journal of the American Academy of Dermatology. 70: 381-3. PMID 24438955 DOI: 10.1016/J.Jaad.2013.10.053 |
0.313 |
|
| 2014 |
Callis Duffin K, Yeung H, Takeshita J, Krueger GG, Robertson AD, Troxel AB, Shin DB, Van Voorhees AS, Gelfand JM. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice British Journal of Dermatology. 170: 672-680. PMID 24266717 DOI: 10.1111/Bjd.12745 |
0.309 |
|
| 2014 |
Ciunci CA, Perini RF, Avadhani AN, Kang HC, Sun W, Redlinger M, Harlacker K, Flaherty KT, Giantonio BJ, Rosen MA, Divgi CR, Song HK, Englander S, Troxel A, Schnall M, et al. Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer. Cancer. 120: 77-85. PMID 24108668 DOI: 10.1002/Cncr.28294 |
0.3 |
|
| 2014 |
Cohen AB, Yarchoan M, Troxel AB, Puttaswamy K, Harlacker K, Loevner LA, Brose MS. Phase II trial of sorafenib in advanced thyroid cancer: A disease site analysis. Journal of Clinical Oncology. 32: e17000-e17000. DOI: 10.1200/Jco.2014.32.15_Suppl.E17000 |
0.31 |
|
| 2014 |
Yarchoan M, Cohen AB, Stopenski SJ, Haddad CA, Scott NL, Ma C, Ransom ER, Troxel AB, Feldman MD, Brose MS. Molecular predictors of response to sorafenib in patients with radioactive iodine-resistant advanced thyroid cancer. Journal of Clinical Oncology. 32: 6088-6088. DOI: 10.1200/Jco.2014.32.15_Suppl.6088 |
0.302 |
|
| 2013 |
Fang P, Tan KS, Troxel AB, Rengan R, Freedman G, Lin LL. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy. Breast Cancer Research and Treatment. 141: 125-33. PMID 23942874 DOI: 10.1007/S10549-013-2663-2 |
0.363 |
|
| 2013 |
Patterson RE, Colditz GA, Hu FB, Schmitz KH, Ahima RS, Brownson RC, Carson KR, Chavarro JE, Chodosh LA, Gehlert S, Gill J, Glanz K, Haire-Joshu D, Herbst KL, Hoehner CM, ... ... Troxel AB, et al. The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes & Control : Ccc. 24: 695-704. PMID 23378138 DOI: 10.1007/S10552-013-0150-Z |
0.331 |
|
| 2013 |
Miller TP, Kavcic M, Li Y, Alonzo TA, Hall M, Huang Y, Gerbing RB, Fisher BT, Luger S, Rubin D, Troxel A, Sung L, Gamis AS, Aplenc R. Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group Blood. 122: 931-931. DOI: 10.1182/Blood.V122.21.931.931 |
0.331 |
|
| 2013 |
Sura K, Tan K, Freedman G, Troxel A, Lin L. Factors Affecting Breast Cancer Patient Quality of Life in Association With Radiation International Journal of Radiation Oncology*Biology*Physics. 87: S115-S116. DOI: 10.1016/J.Ijrobp.2013.06.298 |
0.307 |
|
| 2013 |
Fang P, Tan K, Troxel A, Rengan R, Freedman G, Lin L. High BMI Associated With Worse Quality of Life in Breast Cancer Patients Receiving Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S607. DOI: 10.1016/J.Ijrobp.2013.06.1605 |
0.315 |
|
| 2012 |
Liao K, Freres DR, Troxel AB. A transition model for quality-of-life data with non-ignorable non-monotone missing data. Statistics in Medicine. 31: 3444-66. PMID 22826030 DOI: 10.1002/Sim.5359 |
0.536 |
|
| 2012 |
Brown JC, Troxel AB, Schmitz KH. Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. The Oncologist. 17: 1120-8. PMID 22752068 DOI: 10.1634/Theoncologist.2012-0035 |
0.324 |
|
| 2012 |
Mehta NN, Krishnamoorthy P, Yu Y, Khan O, Raper A, Van Voorhees A, Troxel AB, Gelfand JM. The impact of psoriasis on 10-year Framingham risk. Journal of the American Academy of Dermatology. 67: 796-8. PMID 22739354 DOI: 10.1016/J.Jaad.2012.05.016 |
0.303 |
|
| 2011 |
Keefe SM, Troxel AB, Rhee S, Puttaswamy K, O'Dwyer PJ, Loevner LA, Mandel SJ, Brose MS. Phase II trial of sorafenib in patients with advanced thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5562. PMID 28022142 DOI: 10.1200/Jco.2011.29.15_Suppl.5562 |
0.302 |
|
| 2011 |
Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM. Validity of the Health Improvement Network (THIN) for the study of psoriasis British Journal of Dermatology. 164: 602-609. PMID 21073449 DOI: 10.1111/J.1365-2133.2010.10134.X |
0.301 |
|
| 2010 |
Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. Jama. 304: 2699-705. PMID 21148134 DOI: 10.1001/Jama.2010.1837 |
0.336 |
|
| 2010 |
Halbert CH, Kessler L, Troxel AB, Stopfer JE, Domchek S. Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: A randomized trial Public Health Genomics. 13: 440-448. PMID 20234119 DOI: 10.1159/000293990 |
0.317 |
|
| 2010 |
Schmitz K, Cheville A, Ahmed R, Troxel A. Abstract ES9-3: Balancing Risks of Deconditioning vs. Weight-Lifting for Breast Cancer Survivors Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Es9-3 |
0.355 |
|
| 2009 |
Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP. Weight lifting in women with breast-cancer-related lymphedema New England Journal of Medicine. 361: 664-673. PMID 19675330 DOI: 10.1056/Nejmoa0810118 |
0.331 |
|
| 2009 |
Kontos D, Bakic PR, Carton AK, Troxel AB, Conant EF, Maidment AD. Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk estimation: a preliminary study. Academic Radiology. 16: 283-98. PMID 19201357 DOI: 10.1016/J.Acra.2008.08.014 |
0.305 |
|
| 2009 |
Schmitz KH, Troxel AB, Cheville A, Grant LL, Bryan CJ, Gross CR, Lytle LA, Ahmed RL. Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemporary Clinical Trials. 30: 233-45. PMID 19171204 DOI: 10.1016/J.Cct.2009.01.001 |
0.356 |
|
| 2009 |
Rebbeck TR, DeMichele A, Tran TV, Panossian S, Bunin GR, Troxel AB, Strom BL. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis. 30: 269-74. PMID 19028704 DOI: 10.1093/Carcin/Bgn247 |
0.308 |
|
| 2009 |
Brose MS, Troxel AB, Redlinger M, Harlacker K, Redlinger C, Chalian AA, Flaherty KT, Loevner LA, Mandel SJ, O'Dwyer PJ. Effect of BRAFV600E on response to sorafenib in advanced thyroid cancer patients Journal of Clinical Oncology. 27: 6002-6002. DOI: 10.1200/Jco.2009.27.15_Suppl.6002 |
0.32 |
|
| 2008 |
DeMichele A, Troxel AB, Berlin JA, Weber AL, Bunin GR, Turzo E, Schinnar R, Burgh D, Berlin M, Rubin SC, Rebbeck TR, Strom BL. Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4151-9. PMID 18757329 DOI: 10.1200/Jco.2007.14.0921 |
0.334 |
|
| 2008 |
Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2621-9. PMID 18509174 DOI: 10.1200/Jco.2007.12.3075 |
0.327 |
|
| 2008 |
Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, Gelfand JM. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. Journal of the American Academy of Dermatology. 58: 625-31. PMID 18249471 DOI: 10.1016/J.Jaad.2007.12.035 |
0.305 |
|
| 2008 |
Brose MS, Nellore A, Paziana K, Ransone K, Redlinger M, Flaherty KT, Mandel SJ, Troxel AB, Loevner LA, Gupta-Abramson V. A phase II study of sorafenib in metastatic thyroid carcinoma Journal of Clinical Oncology. 26: 6026-6026. DOI: 10.1200/Jco.2008.26.15_Suppl.6026 |
0.308 |
|
| 2007 |
Gorin SS, Ashford AR, Lantigua R, Desai M, Troxel A, Gemson D. Implementing academic detailing for breast cancer screening in underserved communities. Implementation Science : Is. 2: 43. PMID 18086311 DOI: 10.1186/1748-5908-2-43 |
0.315 |
|
| 2007 |
Rebbeck TR, Troxel AB, Norman S, Bunin G, DeMichele A, Schinnar R, Berlin JA, Strom BL. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk. American Journal of Epidemiology. 166: 1392-9. PMID 17827444 DOI: 10.1093/Aje/Kwm239 |
0.311 |
|
| 2007 |
Vahdat LT, Cohen DJ, Zipin D, Lo KS, Donovan D, Savage D, Tiersten A, Nichols G, Troxel A, Hesdorffer CS. Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer. Bone Marrow Transplantation. 40: 267-72. PMID 17563739 DOI: 10.1038/Sj.Bmt.1705692 |
0.337 |
|
| 2007 |
Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 444-50. PMID 17372239 DOI: 10.1158/1055-9965.Epi-06-0800 |
0.306 |
|
| 2007 |
Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. International Journal of Cancer. Journal International Du Cancer. 120: 1523-8. PMID 17205521 DOI: 10.1002/Ijc.22485 |
0.326 |
|
| 2006 |
Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. The Journal of Investigative Dermatology. 126: 2194-201. PMID 16741509 DOI: 10.1038/Sj.Jid.5700410 |
0.305 |
|
| 2006 |
Jacobson JS, Grann VR, Hershman D, Troxel AB, Li H, Neugut AI. Breast biopsy and race/ethnicity among women without breast cancer. Cancer Detection and Prevention. 30: 129-33. PMID 16621329 DOI: 10.1016/J.Cdp.2006.02.002 |
0.326 |
|
| 2006 |
Gorin SS, Ashford AR, Lantigua R, Hossain A, Desai M, Troxel A, Gemson D. Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. Journal of the American Board of Family Medicine : Jabfm. 19: 110-21. PMID 16513899 DOI: 10.3122/Jabfm.19.2.110 |
0.309 |
|
| 2006 |
Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS. Regional and racial disparities in breast cancer-specific mortality. Social Science & Medicine (1982). 62: 337-47. PMID 16051406 DOI: 10.1016/J.Socscimed.2005.06.038 |
0.322 |
|
| 2005 |
Grann VR, Jacobson JS, Troxel AB, Hershman D, Karp J, Myers C, Neugut AI. Barriers to minority participation in breast carcinoma prevention trials. Cancer. 104: 374-9. PMID 15937913 DOI: 10.1002/Cncr.21164 |
0.318 |
|
| 2005 |
Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 103: 2241-51. PMID 15844176 DOI: 10.1002/Cncr.21030 |
0.305 |
|
| 2005 |
Demichele A, Troxel A, Weber A, Berlin J, Bunin G, Turzo E, Burgh D, Schinnar R, Rubin S, Rebbeck T, Strom B. Effect of raloxifene on endometrial cancer risk in a population-based, case-control study Journal of Clinical Oncology. 23: 5001-5001. DOI: 10.1200/Jco.2005.23.16_Suppl.5001 |
0.33 |
|
| 2004 |
El-Tamer MB, Komenaka IK, Troxel A, Li H, Joseph KA, Ditkoff BA, Schnabel FR, Kinne DW. Men with breast cancer have better disease-specific survival than women. Archives of Surgery (Chicago, Ill. : 1960). 139: 1079-82. PMID 15492147 DOI: 10.1001/Archsurg.139.10.1079 |
0.327 |
|
| 2003 |
Talbot SM, Keohan ML, Hesdorffer M, Orrico R, Bagiella E, Troxel AB, Taub RN. A Phase II Trial of Temozolomide in Patients with Unresectable or Metastatic Soft Tissue Sarcoma Cancer. 98: 1942-1946. PMID 14584078 DOI: 10.1002/Cncr.11730 |
0.32 |
|
| 2002 |
Nichols G, de Castro K, Wei LX, Griffin M, Lin N, Oratzi A, Murty VV, Troxel A, Vahdat L, Hesdorffer C. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer. Leukemia. 16: 1673-9. PMID 12200680 DOI: 10.1038/Sj.Leu.2402631 |
0.319 |
|
| 2001 |
Brenin DR, Manasseh DM, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA, Kinne D. Factors correlating with lymph node metastases in patients with T1 breast cancer. Annals of Surgical Oncology. 8: 432-7. PMID 11407518 DOI: 10.1007/S10434-001-0432-7 |
0.309 |
|
| 2001 |
Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, Neugut AI, Grann VR. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2739-45. PMID 11352967 DOI: 10.1200/Jco.2001.19.10.2739 |
0.349 |
|
| 1998 |
Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. Journal of the National Cancer Institute. 90: 1537-44. PMID 9790546 DOI: 10.1093/Jnci/90.20.1537 |
0.331 |
|
| 1998 |
Troxel AB. A comparative analysis of quality of life data from a southwest oncology group randomized trial of advanced colorectal cancer Statistics in Medicine. 17: 767-779. PMID 9549822 DOI: 10.1002/(Sici)1097-0258(19980315/15)17:5/7<767::Aid-Sim820>3.0.Co;2-B |
0.31 |
|
| Show low-probability matches. |